Effects of ulinastatin and cyclophosphamide on proliferation and invasion of breast cancer cells and expression of matrix metalloproteinase-9

Chinese Journal of Biologicals

Volumn 22, Issue 9, 2009, Pages

  Chen, Jian Sheng ^a   Sun, Zhi Jun ^a   Yu, Tao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer cells; Cyclophosphamide (CTX); Invasion; Matrix metalloproteinase 9 (MMP 9); Proliferation; Ulinastatin (UTI)

Indexed keywords

CYCLOPHOSPHAMIDE; GELATINASE B; ULINASTATIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77953401837     PISSN: 10045503     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novel protease inhibitor and neutral protease activator. Transplant Proc, 2008, 40 (2): 387-389.
2. Kobayashi H, Shinohara H, Cotoh J, et al. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anticancer agent. Br J Cancer, 2000, 72 (5): 1131-1137.
3. Zhang YG, Du Q, Fang WG, et al. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells. Int J Oncol, 2008, 33 (3): 595-602.
4. Inoue K, Takano H, Yanagisawa R, et al. Protective effects of urinary trypsin inhibitor on systemic inflammatory response induced by lipopolysaccharide. J Clin Biochem Nutr, 2008, 43 (3): 139-142.
5. Ueki M, Taie S, Chujo K, et al. Urinary trypsin inhibitor reduces inflammatory response in kidney induced by lipopolysaccharide. J Biosci Bioeng, 2007, 104 (4): 315-320. (Pubitemid 350102407)
6. Kobayeshi H, Suzuki M, Sun GW, et al. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor. Biochim Biophys Acta, 2000, 1481 (2): 310-316.
7. Kobayashi H. Suppression of urokinase expression and tumor metastasis by bikunin overexpression. Hum Cell, 2001, 14 (3): 233-236.
8. Sato N, Endo S, Kimura Y, et al. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg, 2002, 19 (4): 300-305. (Pubitemid 35013736)
9. Nabeshima K, Inous T, Shimao Y, et al. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol International, 2002, 52 (4): 255-264. (Pubitemid 34587810)
10. Sliwowska I, Kopczyński Z. Zymography - method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer. Wiad Lek, 2007, 60 (5-6): 241-247.
11. Kargozaran H, Yuan SY, Breslin JW, et al. A role for endothelial-derived matrix metalloproteinase-2 in breast cancer cell transmigration across the endothelial-basement membrane barrier. Clin Exp Metastasis, 2007, 24 (7): 495-502. (Pubitemid 47524807)
12. Yoshioka I, Tsuchiya Y, Aozuka Y, et al. Urinary trypsin inhibitor suppresses surgical stress-facilitated lung metastasis of murine colon 26-L5 carcinoma cells. Anticancer Res, 2005, 25 (2A): 815-820. (Pubitemid 40546848)